Randomised controlled study of 'physiological' peritoneal dialysis solutions

ISRCTN ISRCTN37099489
DOI https://doi.org/10.1186/ISRCTN37099489
Secondary identifying numbers N0205182207
Submission date
28/09/2007
Registration date
28/09/2007
Last edited
29/03/2018
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Urological and Genital Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr S Fan
Scientific

Department of Renal Medicine and Transplantation
The Royal London Hospital
Whitechapel
London
E1 1BB
United Kingdom

Phone +44 0207 377 7367
Email s.fan@qmul.ac.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use contact details to request a participant information sheet
Scientific titleRandomised controlled study of 'physiological' peritoneal dialysis solutions
Study objectivesWe propose conducting a randomised controlled study of new patients commencing peritoneal dialysis. We shall compare patients who start on 'physiological' (bicarbonate-based) versus 'standard' (lactacte-based) dialysate solution. We propose to study the effect of these solutions on mortality, duration of successful PD and peritonitis rates.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedUrological and Genital Diseases: Peritoneal dialysis
Intervention"Physiological" (pH neutral) versus "standard" (low pH) dialysate solution
Intervention typeOther
Primary outcome measurePatients using physiological solutions will have lower peritonitis rate than control group.
Secondary outcome measures1. Patients using physiological solutions will have better preservation of residual kidney function
2. Patients using physiological solutions will have smaller changes in peritoneal membrane function assessed by PET than control group
3. Patients using physiological solutions will have reduced composite end-point of mortality and PD failure defined by transfer to HD in patients using physiological solutions
Overall study start date29/01/2004
Completion date29/04/2013

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexBoth
Target number of participants131
Key inclusion criteriaAll patients selected to use a PD system that has physiological and standard solutions available
Key exclusion criteria1. Patients unable to provide informed consent
2. Patients where the use of a certain solution is indicated or contra-indicated for medical reasons (eg known allergy)
Date of first enrolment29/01/2004
Date of final enrolment29/04/2013

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Department of Renal Medicine and Transplantation
London
E1 1BB
United Kingdom

Sponsor information

Record Provided by the NHSTCT Register - 2007 Update - Department of Health
Government

The Department of Health, Richmond House, 79 Whitehall
London
SW1A 2NL
United Kingdom

Phone +44 (0)20 7307 2622
Email dhmail@doh.gsi.org.uk
Website http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Government

Barts and The London NHS Trust

No information available

NHS R&D Support Funding

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Editorial Notes

29/03/2018: No publications found, verifying study status with principal investigator
29/01/2016: No publications found, verifying study status with principal investigator